연구개발 새로운 바이오마커와 항암제 개발을 통한 인류의 건강한 미래

Tristetraprolin downregulates the expression of both VEGF and COX-2 in human colon cancer
  • 작성일2021/01/13 16:15
  • 조회 471

Cha HJ, Lee HH, Chae SW, Cho WJ, Kim YM, Choi HJ, Choi DH, Jung SW, Min YJ, Lee BJ, Park SE, Park JW.

Tristetraprolin downregulates the expression of both VEGF and COX-2 in human colon cancer.

Hepatogastroenterology. 2011 May-Jun;58(107-108):790-5. PMID: 21830391